A Phase 2 Randomized Controlled Trial of Selonsertib in Moderate and Severe Diabetic Kidney Disease – Oral abstracts

Document Type

Presentation

Publication Date

11-1-2022

Keywords

washington; spokane; prmc

Clinical Institute

Kidney & Diabetes

Specialty

Endocrinology

Specialty

Nephrology

Comments

Presented at the ASN Kidney Week 2022 Orlando, FL

This document is currently not available here.


Share

COinS